Macro Group Pharmaceutical (Macro Capital) (MCRO) posted a 17.51% year-on-year (YoY) increase in its consolidated net profits after tax and non-controlling interests during the full year ended December 31st 2022, according to financial statments filed to the Egyptian Exchange (EGX) on March 2nd.

The company’s net profits attributable to the parent company grew to EGP 173.835 million in 2022 from EGP 147.929 million in 2021.

Sales soared to EGP 729.611 million last year from EGP 594.259 million the year before.

The firm’s standalone business hit EGP 174.355 million in 2022 from EGP 146.720 million in 2021.

Founded in 2002, Macro Group is a leading Egyptian cosmeceutical company based in Cairo.

 

Copyright © 2022 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).